Literature DB >> 14669817

Use of cellulose powder for the treatment of seasonal allergic rhinitis.

P Josling1, S Steadman.   

Abstract

This study was designed to determine whether a unique cellulose powder extract could prevent the classic hay fever attack from occurring among volunteers who have suffered for some years. Nasaleze enhances nasal mucus, which allows the filtration of allergens, to ensure that only clean air reaches the lungs. One hundred two volunteers were recruited and, using a simple 5-point scoring system to grade their general well-being and severity of any hay fever attacks, the overall average score was 3.85, indicating that Nasaleze was able to control hay fever very well. Rapid relief of symptoms was also demonstrated, sometimes within minutes after inhalation. Overall, 77% of volunteers reported a significant reduction in the number of challenges throughout the study period and most graded Nasaleze as more effective and reported fewer side effects than with a wide range of chemical treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669817     DOI: 10.1007/BF02850092

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  7 in total

Review 1.  Allergic rhinoconjunctivitis: complementary treatments for the 21st century.

Authors:  Simi Kapoor; Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

2.  Efficacy of allergen-blocker mechanical barrier gel on symptoms and quality of life in patients with allergic rhinitis.

Authors:  Seda Sirin Kose; Gizem Atakul; Suna Asilsoy; Ozkan Karaman; Nevin Uzuner; Ozden Anal
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-15       Impact factor: 2.503

3.  The Comparison of Nasaleze and Mometasone Nasal Spray to Control the Symptoms of Allergic Rhinitis.

Authors:  Nafiseh Sadat Mahmoodi; Seyyed Ahmad Reza Okhovat; Seyyed Hamid Reza Abtahi; Amirhossein Moslehi
Journal:  Adv Biomed Res       Date:  2018-02-16

4.  Dehydration affects drug transport over nasal mucosa.

Authors:  Abdullah Ali; Marie Wahlgren; Birgitta Rembratt-Svensson; Ameena Daftani; Peter Falkman; Per Wollmer; Johan Engblom
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

5.  Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.

Authors:  Paul Rennie; Philip Bowtell; David Hull; Duane Charbonneau; Robert Lambkin-Williams; John Oxford
Journal:  Respir Res       Date:  2007-05-17

6.  A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).

Authors:  Pedro Ojeda; Núria Piqué; Alicia Alonso; Julio Delgado; Francisco Feo; Juan Manuel Igea; Ana Navarro; José María Olaguibel; Javier Subiza; Carles Nieto; Morgan Andersson
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-27       Impact factor: 3.406

Review 7.  Brazilian Academy of Rhinology position paper on topical intranasal therapy.

Authors:  João Ferreira de Mello; Olavo de Godoy Mion; Nilvano Alves de Andrade; Wilma Terezinha Anselmo-Lima; Aldo Eden Cassol Stamm; Washingthon Luiz de Cerqueira Almeida; Pedro Oliveira Cavalcante Filho; Jair de Carvalho e Castro; Francini Grecco de Melo Padua; Fabrizio Ricci Romano; Rodrigo de Paulo Santos; Renato Roitmann; Richard Louis Voegels; Roberto Campos Meirelles; Leonardo Conrado Barbosa Sá; Moacyr Tabasnik Moacyr; Marco Cesar Jorge dos Santos; Roberto Eustáquio Santos Guimarães
Journal:  Braz J Otorhinolaryngol       Date:  2013 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.